Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
14 NC counties and 1 VA county are under alert, including Moore and Lee counties.
Program
On WRAL at 6: A Wake deputy with ALS waited months for an insurance payout, until 5 On Your Side stepped in.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
121.44
-0.08 (-0.07%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,311,906
Open
121.85
Bid (Size)
121.76 (5)
Ask (Size)
123.00 (2)
Prev. Close
121.52
Today's Range
121.12 - 122.51
52wk Range
99.14 - 130.24
Shares Outstanding
2,531,374,696
Dividend Yield
2.40%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
US Prescriptions Race For Weight Loss Drugs - Eli Lilly's Zepbound Overtakes Novo Nordisk's Wegovy
Today 10:21 EDT
Latest in weight-loss medication trends: Eli Lilly And Co's Zepbound (tirzepatide) surges past rival Novo Nordisk A/S's Wegovy (semaglutide) in new prescriptions, signaling a shift in the obesity...
Via
Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, March 16
March 16, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of March 11-15, 2024.
Via
Talk Markets
Performance
YTD
+7.24%
+7.24%
1 Month
-4.66%
-4.66%
3 Month
+14.52%
+14.52%
6 Month
+12.63%
+12.63%
1 Year
+14.73%
+14.73%
More News
Read More
Newly Diagnosed Cervical Cancer Patients - Merck's Blockbuster Drug Keytruda Plus Chemoradiotherapy Improves Overall Survival
March 15, 2024
Via
Benzinga
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy (CRT) Significantly Improved Overall Survival (OS) Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer
March 15, 2024
From
Merck & Co., Inc.
Via
Business Wire
Market Analysis: Merck & Co And Competitors In Pharmaceuticals Industry
March 13, 2024
Via
Benzinga
Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus
March 14, 2024
Via
Benzinga
7 Dow Darlings for Investors to Buy for March Market Madness
March 13, 2024
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster
March 13, 2024
Via
InvestorPlace
Topics
ETFs
Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL®9
March 13, 2024
From
Merck & Co., Inc.
Via
Business Wire
Moderna Nears Its First Breakout In Over A Year After Launching Third Cancer Vaccine Test
March 11, 2024
Via
Investor's Business Daily
What's Going On With Moderna Stock On Monday?
March 11, 2024
Via
Benzinga
Merck Completes Acquisition of Harpoon Therapeutics, Inc.
March 11, 2024
From
Merck & Co., Inc.
Via
Business Wire
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
March 09, 2024
Via
Talk Markets
Exposures
Product Safety
Have $2,500? 2 Superior Growth Stocks to Buy in 2024
March 09, 2024
Via
The Motley Fool
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
March 07, 2024
Via
InvestorPlace
Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029
March 07, 2024
Via
Benzinga
Promising HIV Treatment: Phase 2 Clinical Trial Success for Gilead's and Merck's Combo Therapy
March 06, 2024
Via
Benzinga
Biogen's Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlers
March 06, 2024
Via
Benzinga
Gilead and Merck Announce Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24
March 06, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic
March 05, 2024
Via
Benzinga
CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients
March 05, 2024
Via
Benzinga
Merck to Participate in the Barclays 26th Annual Global Healthcare Conference
March 05, 2024
From
Merck & Co., Inc.
Via
Business Wire
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024
Via
FinancialNewsMedia
The Top 3 Dow Stocks to Buy in March 2024
March 04, 2024
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.